Do We Need New Antibiotics?
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388971%3A_____%2F09%3A00340931" target="_blank" >RIV/61388971:_____/09:00340931 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Do We Need New Antibiotics?
Original language description
When antibiotics were introduced to the clinical practice, they became miraculous drugs. Their use resulted in a dramatic decrease of infectious diseases and mortality caused by pathogenic microorganisms. However, during the several last years an evenlydramatic increase in antibiotic resistance has been observed and some infections are becoming, once again, untreatable. Should we thus return to the pre-antibiotic era? Even if bacterial strains resistant to most antibiotics exist they are still in minority and most bacteria are sensitive. Nevertheless, new antibacterial compounds are required to treat particularly dangerous and multiply resistant strains. Several approaches are currently used to discover new natural antimicrobial compounds or at leastnew derivatives of known compounds
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
EE - Microbiology, virology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/IAA500200810" target="_blank" >IAA500200810: Genes determining critical steps in designing the producers of hybrid lincosamide antibiotics</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2009
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů